课题基金 / 基金详情

Study on transcutaneous immunization using peptides of melanomd entigens with high affinity to MHC

Study on transcutaneous immunization using peptides of melanomd entigens with high affinity to MHC
MHC高亲和力黑色素抗原肽经皮免疫研究
批准号:
11470181
负责人:
SAIDA Toshiaki
金额:
$9.28万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

SAIDA Toshiaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In our previous studey, we investigated induction of cytotoxic T lymphocytes ( CTL ) against melanoma cells by means of percutaneous application of epitope peptide of melanoma antigens. Application of mouse-gp100 peptide ( EGSRNQDWL ) but not human gp100 peptide ( KVPPNQDWL ) on tape-stripped skin of ear and abdomen of C57BL/6 mice induced slight immune response against B16 mouse melanoma, which was confirmed by CTL assay.This year, we investigated whether this treatment could induce delayed type hypersensitivity reaction ( DTH ) and inhibit growth of B16 melanoma in vivo. Application of the mouse-gp100 peptide on the tapestripped skin of the ear and abdomen of the mice induced DTH reaction, which was detected by foodpad test. However, growth of B16 melanoma was not significantly inhibited in the mice treated with the application of mouse-gp100 peptide.Seo et al reported strong inhibitory effect on the growth of B16 melanoma with almost the same treatment in this murine melanoma system. However, we could not confirm the excellent results in our study. Further study may be necessary to determine the effect of this unique method of immunization.
期刊论文(76)
专著(0)
科研奖励(0)
会议论文
Ichikawa,T.,et al: "Increased synthesis of hyaluronate enhances motility of human melanoma cells"J.Invest.Dermatol. 113(6). 935-939 (1999)
Ichikawa, T., 等人:“增加透明质酸的合成可增强人类黑色素瘤细胞的运动性”J.Invest.Dermatol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
斎田俊明: "皮膚癌の多段階発癌"Molecular Medicine. 36(4). 416-422 (1999)
Toshiaki Saida:“皮肤癌的多步骤致癌”《分子医学》36(4) (1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kubo,H., et al: "Sequential chemoimmunotherapy with cisplatin, IFN-β, and IL-2 inhibits the growth of B16-F1 melanoma in syngeneic mice"Melanoma Res. 10. 223-229 (2000)
Kubo, H., 等人:“使用顺铂、IFN-β 和 IL-2 的序贯化学免疫疗法抑制同系小鼠中 B16-F1 黑色素瘤的生长”Melanoma Res. 10. 223-229 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kageshita,T., Saida,T. et al: "Growth inhibition of human malignant melanoma transfected with the human IFN-β gene by means of catiuonic liposomes"Melanoma Res. 11. 337-342 (2001)
Kageshita,T.,Saida,T.等:“通过阳离子脂质体转染人IFN-β基因的人恶性黑色素瘤的生长抑制”Melanoma Res. 11. 337-342 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
35
    Noninvasive preoperative skin tumor diagnosis by the gene expression analysis and dermoscopy
    • 批准号:
      21591428
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2009
    • 负责人:
      SAIDA Toshiaki
    • 依托单位:
    Phase I/IIa clinical trial of gene therapy for advanced melanoma using cationic liposomes containing interferon beta gene
    • 批准号:
      15390340
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.96万
    • 财政年份:
      2003
    • 负责人:
      SAIDA Toshiaki
    • 依托单位:
    Development of gene therapy for malignant melanoma with transfection of human IFN-β gene
    • 批准号:
      11557064
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.45万
    • 财政年份:
      1999
    • 负责人:
      SAIDA Toshiaki
    • 依托单位:
    Carcinogenesis Experiments Using Human Skin Xenografted onto SCID-lineage Mice
    • 批准号:
      07670937
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.22万
    • 财政年份:
      1995
    • 负责人:
      SAIDA Toshiaki
    • 依托单位:
    海外基金